APA

Theelen W. S. M. E., Kuilman T., Schulze K., Zou W., Krijgsman O., Peters D. D. G. C., Cornelissen S., Monkhorst K., Sarma P., Sumiyoshi T., Amler L. C., Willems S. M., Blaauwgeers J. L. G., van Noesel C. J. M., Peeper D. S., van den Heuvel M. M. & Kowanetz M. (20200121). Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. : PloS one.

Chicago

Theelen Willemijn S M E, Kuilman Thomas, Schulze Katja, Zou Wei, Krijgsman Oscar, Peters Dennis D G C, Cornelissen Sten, Monkhorst Kim, Sarma Pranamee, Sumiyoshi Teiko, Amler Lukas C, Willems Stefan M, Blaauwgeers Johannes L G, van Noesel Carel J M, Peeper Daniel S, van den Heuvel Michel M and Kowanetz Marcin. 20200121. Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. : PloS one.

Harvard

Theelen W. S. M. E., Kuilman T., Schulze K., Zou W., Krijgsman O., Peters D. D. G. C., Cornelissen S., Monkhorst K., Sarma P., Sumiyoshi T., Amler L. C., Willems S. M., Blaauwgeers J. L. G., van Noesel C. J. M., Peeper D. S., van den Heuvel M. M. and Kowanetz M. (20200121). Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. : PloS one.

MLA

Theelen Willemijn S M E, Kuilman Thomas, Schulze Katja, Zou Wei, Krijgsman Oscar, Peters Dennis D G C, Cornelissen Sten, Monkhorst Kim, Sarma Pranamee, Sumiyoshi Teiko, Amler Lukas C, Willems Stefan M, Blaauwgeers Johannes L G, van Noesel Carel J M, Peeper Daniel S, van den Heuvel Michel M and Kowanetz Marcin. Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. : PloS one. 20200121.